- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Pharmadrug Inc (2): Pharmadrug issues debenture units to replace debentures | 1 | Stockwatch | ||
| PHARMADRUG Aktie jetzt für 0€ handeln | |||||
| Fr | PharmaDrug Inc.: PharmaDrug Announces Issuance of Debenture Units | 624 | Newsfile | Toronto, Ontario--(Newsfile Corp. - November 15, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development... ► Artikel lesen | |
| 31.10. | Pharmadrug Inc (2): Pharmadrug to issue $414,523 in debenture units | 1 | Stockwatch | ||
| 31.10. | PharmaDrug Inc.: PharmaDrug Announces Proposed Issuance of Debenture Units | 338 | Newsfile | Toronto, Ontario--(Newsfile Corp. - October 31, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development... ► Artikel lesen | |
| 31.10. | Pharmadrug Inc (2): Pharmadrug completes PD-001 stability study | 2 | Stockwatch | ||
| 31.10. | PharmaDrug Inc.: PharmaDrug's Sairiyo Therapeutics Announces Successful Completion of Stability Study of PD-001 (Patented Reformulated Cepharanthine) to Support Use in Phase 1 Study for Viral Infectious Diseases | 179 | Newsfile | Toronto, Ontario--(Newsfile Corp. - October 31, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development... ► Artikel lesen | |
| 20.09. | PharmaDrug Subsidiary Begins Prep Work For Clinical Trial Of PD-001 For Viral Infectious Diseases | 4 | The Deep Dive | ||
| 19.09. | Pharmather Holdings Ltd: Pharmadrug begins start-up work for PD-001 study | 2 | Stockwatch | ||
| 19.09. | Pharmadrug Inc (2): Pharmadrug begins start-up work for PD-001 study | 2 | Stockwatch | ||
| 19.09. | PharmaDrug Inc.: PharmaDrug's Sairiyo Therapuetics Announces Initiation of Study Start-Up Activities and Design for Clinical Trial of PD-001 (Patented Reformulated Cepharanthine) for Viral Infectious Diseases | 238 | Newsfile | Toronto, Ontario--(Newsfile Corp. - September 19, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research,... ► Artikel lesen | |
| 28.08. | Pharmadrug Inc (2): Pharmadrug details plans for cepharanthine development | 2 | Stockwatch | ||
| 28.08. | Pharmather Holdings Ltd: Pharmadrug details plans for cepharanthine development | 3 | Stockwatch | ||
| 28.08. | PharmaDrug Subsidiary To Focus Development Of PD-001 On Viral Infectious Diseases | 1 | The Deep Dive | ||
| 28.08. | PharmaDrug Inc.: PharmaDrug's Sairiyo Therapuetics Provides Strategic Plans to Advance PD-001 (Patented Reformulated Cepharanthine) for Viral Infectious Diseases | 397 | Newsfile | Toronto, Ontario--(Newsfile Corp. - August 28, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development... ► Artikel lesen | |
| 21.08. | PharmaDrug: Cepharanthine Identified For Potential To Bind To Monkeypox Proteins In Independent Screening | 3 | The Deep Dive | ||
| 21.08. | PharmaDrug Inc.: PharmaDrug's Sairiyo Therapuetics Announces Independent Screening Identifying Cepharanthine's Potential to Bind to Monkeypox (Mpox) Proteins | 435 | Newsfile | Toronto, Ontario--(Newsfile Corp. - August 21, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development... ► Artikel lesen | |
| 19.08. | Bullish Monday For Marijuana Stocks - Leafbuyer Techs, Pharmadrug Among Top Gainers | 2 | Benzinga.com | ||
| 19.08. | Pharmather Holdings Ltd: Pharmadrug, Pharmather get OK for PD-001 human trial | 1 | Stockwatch | ||
| 19.08. | Pharmadrug Inc (2): Pharmadrug, Pharmather get OK for PD-001 human trial | 2 | Stockwatch | ||
| 19.08. | PharmaDrug Joint Venture Receives Approval For Phase 1 Clinical Trial | 1 | The Deep Dive |
Seite:
1 2 Weiter >>
34 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| AURORA CANNABIS | 4,050 | +0,55 % | Aurora Cannabis Inc (3): Aurora Cannabis releases new recreational products | ||
| CANOPY GROWTH | 3,580 | +0,42 % | Jetzt wird es brenzlig: Kurse von Tilray, Canopy & Co. brechen massiv ein. So heftig könnte es werden | © Foto: Piyapong Thongdumhyu - 123rf StockfotoRund um die US-Wahl fielen weitere Entscheidungen. Während der Cannabis-Sektor die Wahl Trumps zum nächsten US-Präsidenten noch nicht so ganz einordnen... ► Artikel lesen | |
| TILRAY BRANDS | 1,227 | -0,16 % | Prediction: Tilray Brands Won't Be a Cannabis Company in 5 Years | ||
| INNOCAN PHARMA | 0,146 | +4,68 % | Innocan Pharma meldet Finanzergebnisse für das dritte Quartal 2024 | 2,7-facher Umsatzzuwachs im Jahresvergleich auf 24 Mio. US$ im Zeitraum von 9 Monaten
Herzliya, Israel und Calgary, Alberta - 20. November 2024 / IRW-Press / Innocan Pharma Corporation... ► Artikel lesen | |
| TAAT GLOBAL ALTERNATIVES | 0,130 | 0,00 % | XFRA 2TP0: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| DERMAPHARM | 36,550 | -0,95 % | EQS-News: Dermapharm Holding SE mit starkem dritten Quartal 2024, die französische Arkopharma erstmals wieder mit gestiegenem EBITDA gegenüber Vorjahr | EQS-News: Dermapharm Holding SE
/ Schlagwort(e): Quartals-/Zwischenmitteilung/9-Monatszahlen
Dermapharm Holding SE mit starkem dritten Quartal 2024, die französische Arkopharma... ► Artikel lesen | |
| CRONOS GROUP | 1,848 | -2,89 % | Cronos Group Inc. (CRON): A Bull Case Theory | ||
| SYNBIOTIC | 5,580 | -1,41 % | EQS-News: SYNBIOTIC SE: In voller Blüte: WEECO Pharma stärkt Umsatz von SYNBIOTIC | EQS-News: SYNBIOTIC SE
/ Schlagwort(e): Sonstiges
In voller Blüte: WEECO Pharma stärkt Umsatz von SYNBIOTIC
14.11.2024 / 13:30 CET/CEST
Für den Inhalt der Mitteilung... ► Artikel lesen | |
| VIATRIS | 12,365 | -0,80 % | Viatris Inc. Q3 Profit Decreases, But Beats Estimates | WASHINGTON (dpa-AFX) - Viatris Inc. (VTRS) released a profit for third quarter that decreased from the same period last year but beat the Street estimates.The company's earnings came in at $94.8... ► Artikel lesen | |
| TRANSCANNA | 0,017 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM XETRA - 02.07.2024 | The following instruments on XETRA do have their last trading day on 02.07.2024Die folgenden Instrumente in XETRA haben ihren letzten Handelstag am 02.07.2024ISIN NameGB00BMGRFP88 CITIUS RESOURCES LS-... ► Artikel lesen | |
| DIGICANN VENTURES | 0,004 | 0,00 % | CSE Bulletin: Halted for Fundamental Change - Digicann Ventures Inc. (DCNN) | le 30 septembre/September 2024
Trading in the shares of Digicann Ventures Inc. will remain halted pending receipt and review of acceptable documentation regarding the Fundamental Change pursuant... ► Artikel lesen | |
| ORGANIGRAM | 1,386 | -1,98 % | Organigram Reports Third Quarter Fiscal 2024 Results | TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), a leading licensed producer of cannabis, announced its results for the third quarter... ► Artikel lesen | |
| CRESCO LABS | 1,186 | +4,96 % | Cresco Labs Demonstrates Success of Cash Flow Focused Strategy with Third Quarter 2024 Financial Results | Record quarterly operating cash flow of $49 million and year to date operating cashflow of $103 million, an increase of 66% from the prior year period
Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF)... ► Artikel lesen | |
| GREEN THUMB INDUSTRIES | 8,805 | -3,45 % | Grünes Gold!: Gesundheit so wichtig wie nie! Medizinische Revolution durch diese Aktie! | ||
| SNDL | 1,851 | -0,75 % | Cannabis company SNDL to repurchase up to CA$100 million in stock |
PHARMADRUG INC gehört der Branche Pharma an. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 0,001 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu PHARMADRUG INC finden Sie auf Wallstreet Online.
